NFKB1 and B-cell chronic lymphocytic leukemia: The PI3K/AKT/NFκB pathway plays a key role in maintaining survival of CLL cells [5–8], and is also involved in acquisition of microenvironment-mediated resistance to purine analogs like fludarabine [9–11].